G. Hafner

发表

Annexin V does not represent a diagnostic alternative to myoglobin for early detection of myocardial infarction.

S. Blankenberg, M. Möckel, H. Rupprecht, 2002, Clinical laboratory.

Effects of the prostanoid EP3‐receptor agonists M&B 28767 and GR 63799X on infarct size caused by regional myocardial ischaemia in the anaesthetized rat

C. Thiemermann, K. Zacharowski, G. Hafner, 1999, British journal of pharmacology.

Reduction of myocardial infarct size with sCR1sLex, an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x

C. Thiemermann, K. Zacharowski, G. Hafner, 1999, British journal of pharmacology.

Selective activation of the prostanoid EP(3) receptor reduces myocardial infarct size in rodents.

C. Thiemermann, K. Zacharowski, G. Hafner, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Endotoxin induces a second window of protection in the rat heart as determined by using p-nitro-blue tetrazolium staining, cardiac troponin T release, and histology.

C. Thiemermann, K. Zacharowski, G. Hafner, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Multicenter evaluation of a second-generation assay for cardiac troponin T.

H. Katus, Sabine Braun, G. Hafner, 1997, Clinical chemistry.

Association Between P-Selectin Gene Polymorphisms and Soluble P-Selectin Levels and Their Relation to Coronary Artery Disease

S. Blankenberg, L. Tiret, F. Cambien, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis

S. Blankenberg, C. Espinola‐Klein, H. Rupprecht, 2002, Circulation.

Multicenter Evaluation of a Fully Mechanized Soluble Transferrin Receptor Assay on the Hitachi and Cobas Integra Analyzers. The Determination of Reference Ranges

N. Blanckaert, G. Hafner, J. Lotz, 2002, Clinical chemistry and laboratory medicine.

Lipoteichoic acid induces delayed protection in the rat heart: A comparison with endotoxin.

S. Cuzzocrea, C. Thiemermann, J. Pfeilschifter, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Monitoring prothrombin fragment 1+2 during initiation of oral anticoagulant therapy after intracoronary stenting

R. Erbel, H. Rupprecht, G. Hafner, 1992, Annals of Hematology.

Application of C1-Esterase Inhibitor During Reperfusion of Ischemic Myocardium: Dose-Related Beneficial Versus Detrimental Effects

S. Petersen, G. Horstick, O. Götze, 2001, Circulation.

Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion.

G. Horstick, O. Götze, H. Darius, 1997, Circulation.

ProC Global: the first functional screening assay for the complete protein C pathway.

F. Dati, G. Hafner, W. Prellwitz, 1997, Clinical chemistry.

The Harvest Smart PRePTM system versus the Friadent-Schütze platelet-rich plasma kit.

G. Hafner, W. Hitzler, G. Weibrich, 2003, Clinical oral implants research.

Quantification of Thrombocyte Growth Factors in Platelet Concentrates Produced by Discontinuous Cell Separation

G. Hafner, W. Hitzler, W. Wagner, 2002, Growth factors.

Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease.

F. Cambien, S. Blankenberg, L. Tiret, 2003, New England Journal of Medicine.

Genetic and environmental influences on the fibrinolytic system: a twin study

K. Lackner, D. Peetz, G. Hafner, 2004, Thrombosis and Haemostasis.

Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease.

S. Blankenberg, A. Schlitt, H. Rupprecht, 2002, The American journal of cardiology.

Reoperation and the centrifugal pump?

G. Hafner, W. Prellwitz, S. Iversen, 1992, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion.

S. Blankenberg, C. Espinola‐Klein, H. Rupprecht, 2002, International journal of cardiology.

Analytical characteristics of the AxSYM cardiac troponin I and creatine kinase MB assays.

K. Lackner, D. Peetz, G. Hafner, 2002, Clinical chemistry.

Impact of Infectious Burden on Progression of Carotid Atherosclerosis

S. Blankenberg, C. Espinola‐Klein, H. Rupprecht, 2002, Stroke.

Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery Disease

S. Blankenberg, C. Espinola‐Klein, H. Rupprecht, 2001, Circulation.

Are Morphological or Functional Changes in the Carotid Artery Wall Associated With Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus, or Herpes Simplex Virus Infection?

S. Blankenberg, C. Espinola‐Klein, H. Rupprecht, 2000, Stroke.

Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina.

H. Rupprecht, J. vom Dahl, W. Terres, 1995, Journal of the American College of Cardiology.

Cardiac troponins in serum in chronic renal failure.

I. Kupferwasser, G. Hafner, W. Prellwitz, 1994, Clinical chemistry.

Release of choline in the isolated heart, an indicator of ischemic phospholipid degradation and its protection by ischemic preconditioning: no evidence for a role of phospholipase D.

G. Hafner, K. Löffelholz, A. Brühl, 2004, Life sciences.

Reference Values for a Homogeneous Ferritin Assay and Traceability to the 3rd International Recombinant Standard for Ferritin (NIBSC Code 94/572)

G. Hafner, J. Lotz, W. Prellwitz, 1999, Clinical chemistry and laboratory medicine.

Influence of blood sampling from venipunctures and catheter systems on serial determinations of prothrombin activation fragment 1 + 2 and thrombin-antithrombin III complex

G. Hafner, J. Lotz, W. Prellwitz, 1993, Annals of Hematology.

Prothrombin fragments and thrombotic occlusion of coronary stents

R. Erbel, Jürgen Meyer, G. Hafner, 1991, The Lancet.

Troponin T--a reliable marker of perioperative myocardial infarction?

G. Hafner, M. Dahm, F. Schmid, 1993, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[Diagnostic and differential diagnostic value of troponins].

H. Rupprecht, G. Hafner, W. Prellwitz, 1996, Medizinische Klinik.

Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count.

G. Hafner, W. Hitzler, G. Weibrich, 2002, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.

H. Rupprecht, W. Terres, J. Meyer, 1996, European heart journal.

Purpura fulminans in severe congenital protein C deficiency: Monitoring of treatment with protein C concentrate

D. Schranz, G. Hafner, W. Ehrenthal, 2005, European Journal of Pediatrics.

Retinal vascular occlusion and deficiencies in the protein C pathway.

N. Pfeiffer, D. Peetz, G. Hafner, 1999, American journal of ophthalmology.

Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease

S. Blankenberg, L. Tiret, H. Rupprecht, 2001, Circulation.

Evaluation of an automated chromogenic substrate assay for the rapid determination of hirudin in plasma.

H. Rupprecht, G. Hafner, J. Lotz, 1995, Thrombosis research.

Analytical and Clinical Evaluation of Troponin I Determination on Dimension RXL-HM

S. Blankenberg, F. Dati, H. Rupprecht, 2000, Clinical chemistry and laboratory medicine.

Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease

F. Cambien, S. Blankenberg, L. Tiret, 2003, Circulation.

Comparison of diagnostic performance of cardiac troponin I on the IMMULITE system with other automated troponin I assays in minor myocardial damage

S. Blankenberg, H. Rupprecht, D. Peetz, 2001, Scandinavian journal of clinical and laboratory investigation.

Troponin I concentrations of shed blood might influence monitoring of myocardial injury after coronary operations.

D. Peetz, G. Hafner, A. Peivandi, 2001, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Postoperative Reduction of Fibrinolysis as a Prognostic Factor of Fatal Outcome

D. Peetz, G. Hafner, J. Lotz, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report.

G. Hafner, W. Hitzler, G. Weibrich, 2005, The International journal of oral & maxillofacial implants.

Postoperative patterns and kinetics of cTnI, cTnT, CK-MB-activity and CK-activity after elective aortic valve replacement.

G. Hafner, M. Dahm, H. Oelert, 2001, Swiss medical weekly.

[Manifestations of atherosclerosis in various vascular regions. Similarities and differences regarding epidemiology, etiology and prognosis].

S. Blankenberg, H. Rupprecht, Jürgen Meyer, 2002, Medizinische Klinik.

Effects of Periconceptual Omega-3-Fatty Acid Supplementation on in Vitro Fertilization Success and Miscarriage Rates in Patients of a German Fertility Centre

G. Hafner, K. Schlatterer, S. Pfeiffer, 2019, International Journal of Clinical and Experimental Medical Sciences.

Thrombotic Risks: A Clarification To the Editor:

G. Hafner, J. Lotz, W. Prellwitz, 1998 .

The control of anti-coagulation in acute dialyses with sensitive laboratory parameters.

G. Hafner, W. Prellwitz, H. Schinzel, 1992, Scandinavian journal of clinical and laboratory investigation.

Laboratory control of minimal heparinization during haemodialysis in patients with a risk of haemorrhage

G. Hafner, J. Lotz, W. Prellwitz, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Valvular and Congenital Heart Disease Nickel release after implantation of the Amplatzer

G. Hafner, W. Ries, C. Kampmann, 2003 .

Routine extracorporeal circulation with a centrifugal or roller pump.

G. Hafner, W. Prellwitz, H. Oelert, 1991, ASAIO transactions.

Determination of Human Granulocyte Elastase by the Immunoactivation Method on the Hitachi® 717 Automated Analyser

G. Hafner, W. Prellwitz, W. Ehrenthal, 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease.

S. Blankenberg, H. Rupprecht, Jürgen Meyer, 2002, The American journal of cardiology.

Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system.

G. Hafner, G. Weibrich, W. Kleis, 2002, The International journal of oral & maxillofacial implants.

Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank.

G. Hafner, W. Hitzler, W. Wagner, 2003, Clinical oral implants research.

Correlation Between Immunological Laboratory Status of Omega-3-Fatty-Acid-Supplemented Patients of a German Fertility Centre and Outcome of IVF-Treatment

G. Hafner, K. Schlatterer, S. Pfeiffer, 2019, International Journal of Clinical and Experimental Medical Sciences.

Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease.

F. Cambien, S. Blankenberg, L. Tiret, 2003, The New England journal of medicine.

Nickel release after implantation of the Amplatzer occluder.

H. Rupprecht, Jürgen Meyer, G. Hafner, 2003, American heart journal.

Comparison of point-of-care methods for preparation of platelet concentrate (platelet-rich plasma).

G. Hafner, P. Streckbein, W. Hitzler, 2012, The International journal of oral & maxillofacial implants.

Fatal late vitamin K-deficiency bleeding after oral vitamin K prophylaxis secondary to unrecognized bile duct paucity.

M. Shearer, G. Hafner, T. Humpl, 1999, Journal of pediatric gastroenterology and nutrition.

Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation

G. Hafner, P. Toulon, C. Wagner, 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Impact of Viral and Bacterial Infectious Burden on Long-Term Prognosis in Patients With Coronary Artery Disease

S. Blankenberg, H. Rupprecht, G. Hafner, 2001, Circulation.

Methoden zur Bestimmung von Thrombininhibitoren / Methods for the determination of thrombin inhibitors

D. Peetz, G. Hafner, 2006 .

Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease.

S. Blankenberg, A. Schlitt, H. Rupprecht, 2005, International journal of cardiology.

Evaluation of a Point-of-Care System for Quantitative Determination of Troponin T and Myoglobin

Hugo A. Katus, Christer Sylvén, Paul O. Collinson, 2000, Clinical chemistry and laboratory medicine.

Evaluation of the new ImmuliteTurbo cTnI assay and the original Immulite cTnI assay

D. Peetz, G. Hafner, H. Erbes, 2001, Scandinavian journal of clinical and laboratory investigation.

Immunonephelometric Determination of the Apolipoprotein A-II

G. Hafner, W. Prellwitz, C. Luley, 1989, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Immunonephelometric determination of the C4b-binding protein.

G. Hafner, J. Lotz, W. Prellwitz, 1993, Thrombosis research.

Dose-adjusted thrombosis prophylaxis in trauma surgery according to levels of D-Dimer.

P. Rommens, D. Peetz, G. Hafner, 2000, Thrombosis research.

Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines.

F. Cambien, S. Blankenberg, L. Tiret, 2003, The American journal of cardiology.

Methods for the monitoring of direct thrombin inhibitors.

M. Nauck, M. Roser, G. Hafner, 2002, Seminars in thrombosis and hemostasis.

Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation.

A. Schwarting, G. Hafner, R. Klingel, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Guidance of anticoagulation after intracoronary implantation of Palmaz-Schatz stents by monitoring prothrombin and prothrombin fragment 1 + 2.

R. Erbel, H. Rupprecht, J. Meyer, 1995, American heart journal.

The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events.

R Erbel, G Hafner, R. Erbel, 1999, Journal of the American College of Cardiology.

Biochemical bone markers compared with bone density measurement by dual energy X-ray absorptiometry

G. Hafner, J. Lotz, W. Prellwitz, 1995, Calcified Tissue International.

Effects of surface seeding with vital cells on the calcium uptake of biological materials for heart valve replacement.

G. Hafner, M. Dahm, E. Mayer, 1996, Journal of Heart Valve Disease.

Early antithrombotic management after valve replacement

G. Hafner, M. Dahm, E. Mayer, 2001 .

Increase in endogenous fibrinolysis and platelet activity during exercise in young volunteers.

H. Darius, G. Hafner, J. Meyer, 1992, Agents and actions. Supplements.

Effest of Molsidomine on t-PA and PAI Activity in Man: A Double Blind, Placebo Controlled Study

H. Darius, G. Hafner, L. Grodzińska, 1990, Thrombosis and Haemostasis.

Patterns and diagnostic value of cardiac troponin I vs. troponin T and CKMB after OPCAB surgery.

G. Hafner, A. Peivandi, M. Dahm, 2001, The Thoracic and cardiovascular surgeon.

Determination of C-Reactive Protein by an Improved Turbidimetric Assay.

G. Hafner, L. Galanti, R. Röddiger, 1997 .

Genetic thrombophilia in patients with retinal vascular occlusion

N. Pfeiffer, D. Peetz, G. Hafner, 2004, International Ophthalmology.

Inappropriate Blood Transfusion in Neonatal Hemolytic Anemia Due to Anti-c

G. Hafner, Falko Strotmann, Bianca Karnuth, 2017 .

Safety and Efficacy of Single Bolus Anticoagulation with Enoxaparin for Chronic Hemodialysis. Results of an Open-Label Post-Certification Study

A. Schwarting, G. Hafner, M. Eckert, 2004, Kidney and Blood Pressure Research.

The Influence of Fractures on the Risk for Deep Vein Thrombosis Onset - Monitoring by TAT and D-Dimer under Prophylaxis with LMWH -

P. Rommens, D. Peetz, G. Hafner, 2002 .

In Reply: Cardiac Troponin T in End-Stage Renal Disease Patients Undergoing Chronic Maintenance Hemodialysis

I. Kupferwasser, G. Hafner, W. Prellwitz, 1995 .

Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis

S. Blankenberg, H. Rupprecht, Jürgen Meyer, 2002, Circulation.

[Monitoring of the heparin therapy during acute haemodialysis].

G. Hafner, R. Klingel, B. Molitor, 2005, Hamostaseologie.

Prognostic Value of Troponin T,Troponin I, and CK-MBmass in Patients with Chronic Renal Failure

K. Lackner, D. Peetz, G. Hafner, 2003, Medizinische Klinik.

Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report.

G. Hafner, W. Hitzler, G. Weibrich, 2005, The International journal of oral & maxillofacial implants.

Evaluation of a rapid, quantitative cardiac troponin I immunoassay.

G. Hafner, R. Schweigert, W. Prellwitz, 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.